Clinical Trials Browser

Phase 2 × Erlotinib Hydrochloride × Other hematologic neoplasm × Clear all

NCT01174043 2023-10-13

Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia

Phase 2 Completed

11 enrolled 8 charts

Other hematologic neoplasm

Leukemia, Myelomonocytic, Acute

NCT00977548 2013-09-16

Erlotinib Study for Myelodysplastic Syndrome (MDS)

Phase 2 Completed

39 enrolled 10 charts

MyeloidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Myelodysplastic Syndromes